Filetype
Additional material for LUDC publications Plasma concentration of proneurotensin and prediction of cause-specific mortality in a middle-aged cohort during long-term follow-up Ayesha Fawad1, Andreas Bergmann2, Joachim Struck2, Zahra A. Butt3, Peter M Nilsson1, Louise Bennet1, Marju Orho-Melander1, and Olle Melander1 Lund University, Department of Clinical Sciences, Malmo, Sweden Sphingotec GmbH, He
https://www.ludc.lu.se/resources/supplementary-material - 2025-11-27
Year, name and affiliation 2022 Myriam Aouadi, Associate Professor, Karolinska Institute, Centre for infectious Medicine, Stockholm 2021 Stefano Romeo, Professor, Sahlgrenska Akademym, Dept of Molecular and Clinical Medicine, Gothenburg 2020 Niels Grarup, Associate Professor, Copenhagen University, Denmark 2019 Olov Andersson, Professor. Karolinska Institute, Stockholm 2018 Jorge Lira Ruas, Asso
Excellence of diabetes research Read about EXODIAB Industrial research centre Read about LUDC-IRC Quick links Work for usLUDC Early Career NetworkCourses and training Research Award for outstanding diabetes research The Leif C. Groop Award for Outstanding Diabetes Research is awarded by LUDC to a young investigator in the field of diabetes research. Nominate a candidate by December 1. Support di
https://www.ludc.lu.se/home - 2025-11-27
Charlotte Ling’s group Our researchThe goal of our research is to dissect the role of epigenetics in the pathogenesis of type 2 diabetes and develop epigenetic-based therapies and biomarkers for precision medicine.Type 2 diabetes is a multifactorial disease, and combinations of genetic and non-genetic factors such as age, obesity, and physical inactivity increase disease risk. Data from our group
https://www.ludc.lu.se/research/diabetes-epigenetics - 2025-11-27
Adebayo SanusiAdem YesufAngela EstampadorAshfaq AliAzra KurbasicDmitry ShogunFrida RenströmJeremy PomeroyJerneja MislejJohanna EkströmJonathan Dalla-RivaLouise BennetMaria KellerShafqat AhmadSonja RuhnkeYan ChenÅsa Tornberg
https://www.ludc.lu.se/research-0/genetic-and-molecular-epidemiology-game/previous-members - 2025-11-27
Current project/positionDr Norijuki Fuku is an Associate Professor at the Graduate School of Health and Sprots Science, Juntendo University in Japapn. Hir research focuses on the genetics of physical performance and their related-phenotypes such as muscle mass, muscle strentgth, muscle fibre type, maximum oxygen consumption, and so on, as well as on the genetics of adaptation to physical training
https://www.ludc.lu.se/ola-hansson/noriyuki-fuku-associate-researcher-guest-researcher - 2025-11-27
Neelanjan VishnuTitle: Postdoctoral researcherResearch group: Molecular MetabolismCurrent project: to unveil the molecular connection between the cellular ATP generation with plasma membrane oscillation with the focus on insulin homeostasis in the pancreatic beta cells.For more information: http://www.ludc.med.lu.se/research-units/molecular-metabolism/group-mem… Olof AsplundTitle: MSc., PhD studen
https://www.ludc.lu.se/welcome-lund-university-diabetes-centre/new-employees - 2025-11-27
Metabolomics in Cardiometabolic disease - A population-based perspective Background Type 2 diabetes (T2DM) and coronary artery disease (CAD) are major health concerns worldwide, that are preceded by metabolic alterations occuring years before clinical manifestation. These metabolic alterations could be characterized by shifts in plasma levels of metabolites, small molecules that partake in the che
https://www.ludc.lu.se/education-training/theses/theses-2019/filip-ottosson - 2025-11-27
The Role of Maf Transcription Factors in Islet Inflammation and Beta Cell Function Endocrine disorders that lead to a state of chronic high blood glucose levels re collectively referred to as diabetes. This metabolic disease is mainly categorized into type 1 (T1D) and type 2 diabetes (T2D). These diabetic forms aricinate from distinct triggering environmental, genetic and altered mechanisms. T2D i
https://www.ludc.lu.se/education-training/theses/theses-2019/tania-singh - 2025-11-27
Prize winner Olov Andersson, professor KI, Stockholm, Sweden Olov Andersson´s research addresses one of the most important aspects of diabetes: how can we find new targets for effective and safe treatment of these diseases. One major approach Andersson has pursued is stimulation of the generation/regeneration of islet cells, thereby improving insulin secretion. Here, his work has been innovative a
https://www.ludc.lu.se/prize-winner-2018 - 2025-11-27
Under constructionPrel program
https://www.ludc.lu.se/about-us/4th-swedish-diabetes-summit-2020/program - 2025-11-27
Welcome adress
https://www.ludc.lu.se/about-us/4th-swedish-diabetes-summit-2020/welcome - 2025-11-27
For more info on each member of the unit, please follow the links in the left navigation column.
https://www.ludc.lu.se/resources/ludc-bioinformatics-unit/core-personnel - 2025-11-27
Department of Clinical Sciences Malmö Head: Jan Nilsson, PI BackgroundCardiovascular disease (CVD) is a major cause of mortality among subjects with diabetes. The risk of myocardial infarction (MI) is increased 2-3 fold in subjects who have had diabetes for >10 years, with some studies reporting risks equivalent to that of a non-diabetic person with previous MI. Diabetes is also associated with an
https://www.ludc.lu.se/experimental-cardiovascular-research-unit - 2025-11-27
Link to page: www.protein-chemistry.lu.se
https://www.ludc.lu.se/protein-chemistry - 2025-11-27
x
https://www.ludc.lu.se/immunity-and-atherosclerosis - 2025-11-27
Focal accumulation of immune cells and lipids in the vascular wall leads to the formation of atherosclerotic plaques. Plaques occasionally erode or rupture, causing the blood to clot and restrict blood flow, with serious clinical consequences such as acute myocardial infarctions and strokes. Even though our understanding of the disease mechanisms underlying atherosclerosis has advanced substantial
More information to come
https://www.ludc.lu.se/covid-tracker/read-more - 2025-11-27
